When was Phlow founded?

Phlow was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is Phlow located?

Phlow is headquartered in Richmond, United States.

Who is the current CEO of Phlow?

Eric Edwards Md of Phlow. They have also founded 1 company.

How many employees does Phlow have?

As of Aug 31, 2026, the latest employee count at Phlow is 105.

Is Phlow a funded company?

Phlow is a funded company, having raised a total of $122M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 19, 2020.

When was the latest funding round of Phlow?

Phlow's latest funding was a $***** Series C round on Jan 31, 2025, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $902M in funding in 2026 to date.

Where does Phlow rank among its competitors?

Phlow ranks 16th amongst 969 active competitors, of which 38 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Embio, which secured $50M in May, 2026.

Who are the top competitors of Phlow?

Phlow's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem. Among them, Embio secured the most recent funding round in May, 2026.

Phlow - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: www.phlow-usa.com/
Social
Email ID: *****@phlow-usa.com

Key Metrics

Founded Year

2020

Location

Richmond, United States

Stage

Series C

Total Funding

$122M in 6 rounds

Latest Funding Round

Series C, Jan 31, 2025, $*****

Investors

Align Private Capital

Ranked

16^th among 969 active competitors

Employee Count

105 as on Aug 31, 2026

Similar Companies

Laurus Labs & 1233 more

View Phlow's full profile

Phlow has raised a total funding of $122M over 6 rounds. Its first funding round was on May 19, 2020. Its latest funding round was a Series C round on Jan 31, 2025 for $*****. 1 investor participated in its latest round. Phlow has 1 institutional investor.

Here is the list of recent funding rounds of Phlow:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 31, 2025	5759308	Series C	3614677	4724135	8719428	4260918
Jun 28, 2024	1512639	Series B	9588429	4965576	1912772	6927867
Apr 05, 2023	8470098	Series B	4109299	7525072	4325786	4251254

Access funding benchmarks and valuations. Sign up today!

View details of Phlow's funding rounds and investors

The founders of Phlow is Eric Edwards Md. Eric Edwards Md is the CEO of Phlow.

Here are the details of Phlow's key team members:

Eric Edwards Md: Co-Founder and CEO of Phlow and founder of 1 other company.

View details of Phlow's Founder profiles and Board Members

Phlow's employee count trend

Phlow has 105 employees as of Aug 26. Here is Phlow's employee count trend over the years:

Uncover Phlow's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Phlow include Laurus Labs, Symbiotec and NGL Fine Chem. Here is the list of Top 10 competitors of Phlow, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Laurus Labs 2005, Hyderabad (India), Public	Pharmaceutical and biotechnology company	$230M	F-Prime Capital, IKP Knowledge Park & 3 others	78/100
2nd	Symbiotec 2002, Indore (India), Acquired	Manufacturer of non sterile steroid hormone based APIs and intermediates	$61.1M	Franklin Templeton Investments, Actis & 21 others	64/100
3rd	NGL Fine Chem 1981, Mumbai (India), Public	CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals	-	-	59/100
4th	Neuland 1984, Hyderabad (India), Public	Manufacturer of active pharmaceutical ingredients (APIs) and peptides	-	India Capital Growth, InvAscent & 1 others	58/100
5th	Embio 1986, Mumbai (India), Late Stage	Contract research and manufacturing company engaged in APIs and chiral intermediates	$50.3M	UTI, GURU NARAYAN FINCAP & 26 others	58/100
6th	Snapdragon Chemistry 2014, Cambridge (United States), Acquired	CDMO providing API development, manufacturing, and analytical services	-	Asymchem, C2I Accelerator & 1 others	55/100
7th	SeQuent 2002, Bengaluru (India), Acquired	APIs Manufacturer	-	Nepean Capital, Thecarlylegroup.fr & 2 others	54/100
8th	ST PHARM 2008, Siheung si (South Korea), Public	CDMO providing oligonucleotide, mRNA, and small molecule services	-	E&Investment, Synergy IB investment & 1 others	54/100
9th	Hikal 1988, Mumbai (India), Public	Traditional company offering contract research, custom synthesis & custom manufacturing of APIs and intermediates	-	IFC	53/100
10th	Enaltec Labs 2006, Mumbai (India), Acquired	Provider of complex small-volume technology-driven pharmaceutical products	$8.56M	InvAscent, Medtech Global & 7 others	53/100
16th	Phlow 2020, Richmond (United States), Series C	CDMO focused on manufacturing of API products for biopharma sector	$122M	Align Private Capital	46/100